ClinicalTrials.gov
ClinicalTrials.gov Menu

Metacognitive Therapy for Comorbid Insomnia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00235365
Recruitment Status : Withdrawn (problems recruiting patients)
First Posted : October 10, 2005
Last Update Posted : November 22, 2012
Sponsor:
Information provided by (Responsible Party):
Norwegian University of Science and Technology

Brief Summary:
The purpose of this study is to determine the effect of meta-cognitive therapy for insomnia.

Condition or disease Intervention/treatment Phase
Secondary Insomnia Behavioral: meta-cognitive therapy Other: waiting list Not Applicable

Detailed Description:
This study is a randomized controlled trial with 50 patients with a psychiatric disorder and insomnia. The patients will be randomized into two groups of 25 patients. The first group receives meta-cognitive therapy, whereas the second group will be assigned to a waiting list control.

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 0 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Metacognitive Therapy for Patients With a Psychiatric Disorder and Comorbid Insomnia.
Study Start Date : August 2009
Actual Primary Completion Date : January 2011
Actual Study Completion Date : January 2011

Arm Intervention/treatment
Experimental: meta-cognitive therapy
meta-cognitive therapy
Behavioral: meta-cognitive therapy
Meta-cognitive therapy

Active Comparator: waiting list
waiting list control
Other: waiting list
waiting list control




Primary Outcome Measures :
  1. Scores on rating scales for sleep quality [ Time Frame: one year ]

Secondary Outcome Measures :
  1. Scores on rating scales for depression, psychiatric symptom severity, and cognitive processing. [ Time Frame: one year ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Insomnia secondary to a primary psychiatric disorder

Exclusion Criteria:

  • substance abuse, psychotic symptoms, suicidal intentions, severe organic disorder or psychiatric disorder where sleep restriction is not advised, organic sleep disorder.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00235365


Sponsors and Collaborators
Norwegian University of Science and Technology
Investigators
Principal Investigator: Gunnar Morken, PhD MD Norwegian University of Science and Technology

Responsible Party: Norwegian University of Science and Technology
ClinicalTrials.gov Identifier: NCT00235365     History of Changes
Other Study ID Numbers: S2005.2.gr
First Posted: October 10, 2005    Key Record Dates
Last Update Posted: November 22, 2012
Last Verified: November 2012

Additional relevant MeSH terms:
Sleep Initiation and Maintenance Disorders
Sleep Disorders, Intrinsic
Dyssomnias
Sleep Wake Disorders
Nervous System Diseases
Mental Disorders